NEW YORK (GenomeWeb) – Startup molecular diagnostic firm Prominex announced today it has raised $4 million in Series A1 financing.
The funding comes from Casdin Capital and Paul Thomas, a cofounder and CEO of Prominex and former CEO of Roka Bioscience.
Prominex will use the funding to further develop its technology — including a coupled hairpin amplification system, or CHASE, and waveguide detection — for highly multiplexed infectious disease assays, in partnership with point-of-care instrument developer Invetech.